Home > Insider Trading > Filing (0001209191-23-026925)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1681682	Endra Life Sciences Inc.	NDRA	()	CA

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1083544	Anthony Digiandomenico	C/O Endra Life Sciences Inc. 3600 Green Court, Suite 350 Ann Arbor MI 48105		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-02	83,333	$1.20	102,434	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Acquisiton	2023-05-02	41,667	$0.01	41,667	$1.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
41,667	2023-05-02	2028-05-02	No	4	P	Direct

Footnotes

Represents shares purchased in the Registrant's underwritten public offering that closed May 2, 2023 (the "Offering").
The public offering price for each set of two shares of common stock and accompanying warrant to purchase one share of common stock was $2.41 per set of securities, yielding an effective price of $1.20 per share and $0.01 per warrant in the Offering.
Represents warrants purchased in the Offering. The warrants were offered and sold at the rate of one warrant to purchase one share for every two shares of common stock purchased in the Offering.